You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

69 search results for: quality of life

New Perspectives in Understanding the Pathophysiology <b>of</b> Atopic Dermatitis in Children - Expert Interview
expert video

New Perspectives in Understanding the Pathophysiology of Atopic Dermatitis in Children - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Stephan Weidinger explores the pathophysiology and current unmet needs in pediatric atopic dermatitis
View more
Practical Considerations for the Management <b>of</b> Children With Moderate-to-severe Atopic Dermatitis - Expert Interview
expert video

Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Amy Paller discusses unmet needs and therapeutic considerations for pediatric patients with atopic dermatitis
View more
Type 2 Inflammatory Disease Trajectories: Unraveling Patterns <b>of</b> Disease Development and Burden in Pediatric Patients
expert video

Type 2 Inflammatory Disease Trajectories: Unraveling Patterns of Disease Development and Burden in Pediatric Patients

Type 2 Inflammation
Dr. Leonard Bacharier presents potential disease trajectories and burden for pediatric patients with type 2 inflammatory diseases.
View more
Importance <b>of</b> Endotyping in CRSwNP
expert video

Importance of Endotyping in CRSwNP

Rhinology
Prof. Wytske Fokkens discusses the role of endotyping in the management of CRSwNP.
View more
GINA-Based Opportunities for Improved Outcomes With Effective Management <b>of</b> Pediatric Asthma in Children 6-11 Years <b>of</b> Age
interactivity

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Pulmonology
Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.
View more
Beyond the Signs ​and Symptoms: ​The Developmental Burden <b>of</b> AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

Skin Dyspigmentation In Prurigo Nodularis (PN)

Dermatology
This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.
View more
IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective
expert video

IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective

Rhinology
Prof. Eugenio De Corso describes the importance of real-world evidence for understanding the prospects of remission and the emerging evidence of biologic effectiveness for patients with CRSwNP.
View more
Asthma White Board Video
videoanimation

Asthma White Board Video

Pulmonology
Learn about type 2 inflammation in asthma, and the burden of asthma on patients and their families.
View more
Chronic Spontaneous Urticaria (CSU) Interactive Patient Case
interactivity

Chronic Spontaneous Urticaria (CSU) Interactive Patient Case

Dermatology
Learn more about the guideline-based diagnosis of chronic spontaneous urticaria with this interactive patient case.
View more
Concerns Surrounding OCS Side Effects in Patients With Severe Asthma
expert video

Concerns Surrounding OCS Side Effects in Patients With Severe Asthma

Pulmonology
Review the possible consequences of regular oral corticosteroid use in asthma.
View more
Atopic Dermatitis Leads to Sleep Disruption for Children and Their Caregivers
expert video

Atopic Dermatitis Leads to Sleep Disruption for Children and Their Caregivers

Dermatology
Explore the impact of moderate-to-severe atopic dermatitis on sleep in pediatric patients – a short soundbite from EADV 2022.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Hong KongChange country/region